-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Kazia Therapeutics, Raises Price Target to $40

Benzinga·09/01/2026 14:56:19
Listen to the news
BTIG analyst Kambiz Yazdi maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and raises the price target from $34 to $40.